(Q34375885)

1 August 2017

1 reference

title

Clinical benefits of early triptan therapy for migraine. (English)

1 reference

1 August 2017

1 reference

Mja Láinez

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

1 August 2017

1 reference

1 August 2017

volume

24 Suppl 2

1 reference

1 August 2017

page(s)

24-30

1 reference

Migraine diagnosis and treatment: results from the American Migraine Study II.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

Almotriptan improves response rates when treatment is within 1 hour of migraine onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

Early intervention with almotriptan improves sustained pain-free response in acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

What do patients want from acute migraine treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

Migraine--current understanding and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

Migraine pathophysiology and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00895.X

10.1111/J.1468-2982.2004.00895.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference